Hoskin P - Search Results

1

Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.

Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM; EMBRACE Collaborative Group. Nomden CN, et al. Among authors: hoskin p. Radiother Oncol. 2019 May;134:185-190. doi: 10.1016/j.radonc.2019.02.007. Epub 2019 Feb 26. Radiother Oncol. 2019. PMID: 31005214 Free article.

2

Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer.

Hoskin PJ, Rajan B, Ebbs S, Tait D, Milan S, Yarnold JR. Hoskin PJ, et al. Radiother Oncol. 1992 Oct;25(2):83-8. doi: 10.1016/0167-8140(92)90013-k. Radiother Oncol. 1992. PMID: 1438939

3

Changes in applicator position with fractionated high dose rate gynaecological brachytherapy.

Hoskin PJ, Cook M, Bouscale D, Cansdale J. Hoskin PJ, et al. Radiother Oncol. 1996 Jul;40(1):59-62. doi: 10.1016/0167-8140(96)01746-x. Radiother Oncol. 1996. PMID: 8844889

4

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.

Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S, Denekamp J, Stratford MR, Dennis MF, Rojas AM. Saunders MI, et al. Among authors: hoskin pj. Radiother Oncol. 1997 Nov;45(2):159-66. doi: 10.1016/s0167-8140(97)00151-5. Radiother Oncol. 1997. PMID: 9424007 Clinical Trial.

5

A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas.

Goodchild K, Hoskin P, Dische S, Pigott K, Powell M, Saunders M. Goodchild K, et al. Among authors: hoskin p. Radiother Oncol. 1999 Jan;50(1):29-31. doi: 10.1016/s0167-8140(99)00013-4. Radiother Oncol. 1999. PMID: 10225554

6

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations.

Powell ME, Collingridge DR, Saunders MI, Hoskin PJ, Hill SA, Chaplin DJ. Powell ME, et al. Among authors: hoskin pj. Radiother Oncol. 1999 Feb;50(2):167-71. doi: 10.1016/s0167-8140(98)00123-6. Radiother Oncol. 1999. PMID: 10368040

7

High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer.

Hoskin PJ. Hoskin PJ. Radiother Oncol. 2000 Dec;57(3):285-8. doi: 10.1016/s0167-8140(00)00290-5. Radiother Oncol. 2000. PMID: 11104887

8

Metastatic spinal cord compression: radiotherapy outcome and dose fractionation.

Hoskin PJ, Grover A, Bhana R. Hoskin PJ, et al. Radiother Oncol. 2003 Aug;68(2):175-80. doi: 10.1016/s0167-8140(03)00191-9. Radiother Oncol. 2003. PMID: 12972313

9

High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions.

Hoskin PJ, Bownes PJ, Ostler P, Walker K, Bryant L. Hoskin PJ, et al. Radiother Oncol. 2003 Sep;68(3):285-8. doi: 10.1016/s0167-8140(03)00203-2. Radiother Oncol. 2003. PMID: 13129636

10

High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.

Hoskin PJ, de Canha SM, Bownes P, Bryant L, Glynne Jones R. Hoskin PJ, et al. Radiother Oncol. 2004 Nov;73(2):195-8. doi: 10.1016/j.radonc.2004.06.004. Radiother Oncol. 2004. PMID: 15542167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters